Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors
All authors: Udvorková N, Blahová V, Malchárková P, Jochová S, Kaľavská K, Fekiačová A, Pavel J, Horák S, Džongov A, Janko J, Pastorek M, Chovanec M, Čierna Z, Mego M, Kučerová L.
Biomedicine & Pharmacotherapy 2025 Oct 24;192:118659. doi: 10.1016/j.biopha.2025.118659.
PMID: 41138655